This podcast is supported in part by the New England Innovation Academy in Marlborough, Massachusetts,

where today's students become tomorrow's innovators by discovering their passions and purpose while preparing for what's next,

reimagining education with a future-focused curriculum, entrepreneurial mindset, and real-world application,

currently enrolling grade 6 through 12, day and boarding students. Learn more at

NEI Academy.org.

Let's turn now to an announcement made during that White House event about autism. The FDA said it was

approving an old generic drug called leukovorin, long used to treat the toxic effects of chemotherapy

as a therapy for some people with autism.

The active ingredient is a modified version of vitamin B9, also known as folate.

Officials claimed it could help stem what they called an epidemic of autism.

Estimates show about one in 31 children are diagnosed with autism.

Among boys, that number is one in 20.

Once again, here's the president.

The meteoric rise in autism is among the most alarming public health developments in history.

There's never been anything like this.

So we're going to save a lot of children from a tough life, really tough life. We're going to save a lot of children from a tough life, really tough life.

We're going to save a lot of parents from a tough life.

For more on this, I'm joined now by Zoe Gross.

She's Director of Advocacy at the Autistic Self Advocacy Network.

Zoe, good to see you.

Thanks for being here.

Thank you for having me.

...